How much has sickle cell blood demand risen?

NHS calls for more Black blood donors as demand surges

The UK’s National Health Service is urging more people—particularly Black donors—to come forward after demand for blood for sickle cell disease treatment rose sharply.

Sickle cell disease is a rare inherited blood disorder that often requires ongoing transfusion support. The new reporting highlights that demand for blood to treat rare disorders such as sickle cell has climbed by more than 130% over the past 10 years, underscoring how shortages or donor gaps can quickly translate into pressure on clinical services.

Why it matters is straightforward: matching blood types matters. For patients who need regular transfusions, delays or reduced availability can affect care continuity, and the NHS relies on donor diversity to improve compatibility and strengthen the blood supply.

The NHS message focuses on expanding the donor pool—especially among Black communities—because genetic ancestry can influence the likelihood of finding compatible donors for patients. Increasing participation helps blood services maintain a wider range of matched units and improves the odds that patients can receive appropriate blood products when needed.

This kind of donor recruitment drive also carries a public-health angle: it’s not only about meeting a momentary need, but about building stable capacity as rare disease prevalence, treatment needs, and transfusion demand evolve over time.

As demand continues to increase, the practical takeaway for readers is to consider donating if eligible and to share information through community channels to encourage first-time and repeat donors—particularly in groups historically underrepresented in donor registries.